Stallergenes Greer enters partnership to develop device and app

Stallergenes Greer and Aptar Pharma will collaborate to develop a new connected device with a companion app for patients going through treatment with the allergy company's allergen immunotherapy.
Photo: Joachim Adrian
Photo: Joachim Adrian
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY DANIEL PEDERSEN

The allergy company Stallergenes Greer has entered into a partnership with Aptar Pharma regarding the development of a novel connected device and a companion mobile app, the former reports in a press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading